Elastomeric Infusion Pumps Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers Elastomer Infusion Pump Market Trends and it is segmented by Product Type (Continuous Rate Elastomeric Pump and Variable Rate Elastomeric Infusion Pump), Application (Pain Management, Chemotherapy, Chelation Therapy, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others) and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America. The market provides the value (in USD million) for the above-mentioned segments.

Elastomeric Infusion Pumps Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Elastomeric Infusion Pumps Market Size

elastomeric pump
Study Period 2019 - 2030
Market Size (2025) USD 0.81 Billion
Market Size (2030) USD 1.03 Billion
CAGR (2025 - 2030) 4.95 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration High

Major Players

Global Elastomeric Infusion Pumps Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Elastomeric Infusion Pumps with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Elastomeric Infusion Pumps Market Analysis

The Global Elastomeric Infusion Pumps Market size is estimated at USD 0.81 billion in 2025, and is expected to reach USD 1.03 billion by 2030, at a CAGR of 4.95% during the forecast period (2025-2030).

The COVID-19 pandemic had an impact on the healthcare industry. The outbreak of COVID-19 led to disruption, challenges, limitations, and changes in each sector of every industry. The COVID-19 pandemic is expected to have a significant impact on the market. Due to the rising number of COVID-19 cases and related hospitalization, the demand for elastomeric infusion pumps increases to deliver drugs safely in intensive care units. For instance, according to an article published in September 2020, titled 'Elastomeric pumps for symptom control medication in patients dying with COVID-19', it has been observed that elastomeric infusion pumps are more effective for delivering continuous subcutaneous infusions (CSCIs) in palliative care as compared to syringe drivers. Thus, considering elastomeric pumps as a more viable alternative for administering medications in COVID-19 patients as well as in avoiding contamination the demand for its adoption in intensive care units has increased which has impacted the market during a pandemic.

Certain factors that are propelling the market growth are the advancements in the device technologies and the advantages of the elastomeric pumps and the growing burden of chronic diseases.

The rising prevalence of chronic diseases is the key factor driving market growth. For instance, according to the International Diabetes Federation Diabetes Atlas Tenth edition December 2021, around 537 million adults all over the world were found to have diabetes in 2021 and this number is projected to grow to 643 million by 2030 and 783 million by 2045. Also, according to World Health Organization (WHO) data published in April 2021, chronic diseases are expected to kill 41 million people each year, equivalent to 71% of all deaths globally. In low- and middle-income countries chronic disease death accounted for 77%. Similarly, according to an article published in May 2022, titled 'Osteomyelitis', it has been found that 50,000 cases of osteomyelitis are reported each year in the United States. In addition, as per the same source, the incidence of osteomyelitis is higher in men as compared to women and increases with age which is due to the increasing prevalence of comorbid factors such as diabetes mellitus and peripheral vascular disease. Thus, the rising burden of chronic disease among the population is expected to increase the demand for delivering medications safely via intravenous route, which in turn is expected to increase the demand for elastomeric infusion pumps, thereby fueling the market growth.

Similarly, as per an article titled '5 Most Common Cardiac Surgeries in India' published in October 2021, doctors perform over 500,000 open heart surgeries worldwide every year, and in India, alone doctors perform over 60,000 open heart surgeries yearly. With the incidence of cardiac disorders rising, the need to know about their possible treatments is increasing too. Thus, the increasing number of cardiac surgeries rise the demand for infusion pumps for continuous delivery of medications, which is expected to drive the demand for elastomeric infusion pumps, thereby propelling the market growth.

In addition, the elastomeric infusion pump system offers several advantages over electronic pumps including portability, feasible demonstration, low weight, size, ease of use, and less interference with sleep.

Moreover, the growing advancements in devices and technologies are also contributing to market growth. For instance, In November 2020, Ambu Inc. entered an agreement with Intalere for pain care management solutions. In this agreement, Intalere members would receive the Ambu ACTionTM Block Pain Pump. The pump enables anesthesiologists to customize the infusion approach to best meet each patient's specific pain demands throughout the course of treatment and delivers a continuous, stable supply of local anesthetic to the nerve block catheter.

However, the safety issues and disadvantages associated with the pumps and the high cost in long-term use, and strict regulations are some of the factors that are hindering the market growth.

Elastomeric Infusion Pumps Industry Overview

The market is moderately fragmented and competitive. The market players are focusing on new product launches, collaboration, and innovations to expand their market share. The companies operating in the elastomeric infusion systems market are Baxter International, B. Braun Melsungen AG, Avanos Medical, Inc., Nipro Corporation, and Leventon S.A.U among others.

Elastomeric Infusion Pumps Market Leaders

  1. Baxter International

  2. B. Braun Melsungen AG

  3. Nipro Corporation

  4. Leventon, S.A.U

  5. Avanos Medical, Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Elastomeric Infusion Pumps Market - CL.png
Need More Details on Market Players and Competiters?
Download PDF

Elastomeric Infusion Pumps Market News

  • In March 2022, Shanghai MicroPort Lifesciences Co., Ltd. received marketing approval from China's National Medical Products Administration (NMPA) for its independently developed new AutoEx Chemotherapy Infusion Pump (AutoEx).
  • In February 2021, Mindray Medical has launched BeneFusion e series-esp, evp, and eds, new infusion systems for expanding its product portfolio.

Elastomeric Infusion Pumps Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Advancements in Device Technologies and Advantages of the Elastomeric Pumps
    • 4.2.2 Growing Burden of Chronic Diseases
  • 4.3 Market Restraints
    • 4.3.1 Safety Issues and Disadvantages Associated with the Pumps
    • 4.3.2 High Cost in Long-Term Use and Strict Regulations
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value in USD million)

  • 5.1 By Product Type
    • 5.1.1 Continuous Rate Elastomeric Infusion Pumps
    • 5.1.2 Variable Rate Elastomeric Infusion Pumps
  • 5.2 By Application
    • 5.2.1 Pain Management
    • 5.2.2 Chemotherapy
    • 5.2.3 Chelation Therapy
    • 5.2.4 Others
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle-Eastst and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Ambu A/s
    • 6.1.2 Avanos Medical Inc.
    • 6.1.3 Baxter International Inc.
    • 6.1.4 B. Braun Melsungen AG
    • 6.1.5 Werfenlife SA (LeVenton SAU)
    • 6.1.6 Nipro Corporation
    • 6.1.7 Woo Young Medical Co.
    • 6.1.8 Epic Medical Pte Ltd
    • 6.1.9 Daiken Medical Co. Ltd
    • 6.1.10 Smiths Medical Inc. (Smiths Group)
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Elastomeric Infusion Pumps Industry Segmentation

As per the scope of the report, elastomeric infusion pumps, also known as balloon pumps, are non-electronic and disposable that deliver fluids such as analgesics, and antibiotics, among others into the patient's body in controlled amounts. The Elastomeric Infusion Pumps Market is segmented by Product Type (Continuous Rate Elastomeric Pump and Variable Rate Elastomeric Infusion Pump), Application (Pain Management, Chemotherapy, Chelation Therapy, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others) and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America. The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Type Continuous Rate Elastomeric Infusion Pumps
Variable Rate Elastomeric Infusion Pumps
By Application Pain Management
Chemotherapy
Chelation Therapy
Others
By End User Hospitals
Ambulatory Surgical Centers
Others
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa GCC
South Africa
Rest of Middle-Eastst and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Elastomeric Infusion Pumps Market Research FAQs

How big is the Global Elastomeric Infusion Pumps Market?

The Global Elastomeric Infusion Pumps Market size is expected to reach USD 0.81 billion in 2025 and grow at a CAGR of 4.95% to reach USD 1.03 billion by 2030.

What is the current Global Elastomeric Infusion Pumps Market size?

In 2025, the Global Elastomeric Infusion Pumps Market size is expected to reach USD 0.81 billion.

Who are the key players in Global Elastomeric Infusion Pumps Market?

Baxter International, B. Braun Melsungen AG, Nipro Corporation, Leventon, S.A.U and Avanos Medical, Inc. are the major companies operating in the Global Elastomeric Infusion Pumps Market.

Which is the fastest growing region in Global Elastomeric Infusion Pumps Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Elastomeric Infusion Pumps Market?

In 2025, the North America accounts for the largest market share in Global Elastomeric Infusion Pumps Market.

What years does this Global Elastomeric Infusion Pumps Market cover, and what was the market size in 2024?

In 2024, the Global Elastomeric Infusion Pumps Market size was estimated at USD 0.77 billion. The report covers the Global Elastomeric Infusion Pumps Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Elastomeric Infusion Pumps Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Elastomeric Infusion Pumps Industry Report

Statistics for the 2025 Global Elastomeric Infusion Pumps market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Elastomeric Infusion Pumps analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.